Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION)
Volume 52 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
ZHAO Kun, SHI Rong-chen, MIAO Hong-ming. A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION), 2021, 52(1): 45-49. doi: 10.12182/20210160202
Citation: ZHAO Kun, SHI Rong-chen, MIAO Hong-ming. A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCE EDITION), 2021, 52(1): 45-49. doi: 10.12182/20210160202

A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages

doi: 10.12182/20210160202
More Information
  • Corresponding author: E-mail: hongmingmiao@sina.com
  • Received Date: 2020-11-03
  • Rev Recd Date: 2020-12-10
  • Publish Date: 2021-01-20
  • Tumor associated macrophages (TAMs) are one of the most common types of stromal cells in solid tumors. They are closely related to the immunosuppressive status of tumor microenvironment and potentiate the malignant progress of tumors. Studies have shown that metabolism in tumor associated macrophages has been reprogrammed and involved in the regulation of their own polarization and corresponding functions and phenotypes. Metabolic reprogramming refers to the alteration of key enzymes activity, substrate and its associated metabolites’ concentration in a certain metabolic pathway, which accounts for the disorder of original metabolic states. In this paper, we mainly concentrated on the lipid metabolic reprogramming of TAMs, including triglycerides, fatty acids and their derivatives, cholesterol, phospholipids, and their regulations on tumor progression. However, the metabolism of tumor and tumor microenvironment cells is highly heterogeneous. It is worthy of further exploration on the similarities and differences of lipid metabolism reprogramming between stromal cells and tumor cells, and the mechanism of how reprogramming modulates cell activity. It will be a new strategy for immunotherapy of tumor with metabolic intervention to accurately target the lipid metabolism reprogramming of TAMs, so as to promote the polarization of TAMs to M1 like macrophages, when synthetically considering the diverse types of tumors and different stages of development.
  • loading
  • [1]
    VITALE I, MANIC G, COUSSENS L M, et al. Macrophages and metabolism in the tumor microenvironment. Cell Metab,2019,30(1): 36–50. doi: 10.1016/j.cmet.2019.06.001
    [2]
    MEHLA K, SINGH P K. Metabolic regulation of macrophage polarization in cancer. Trends Cancer,2019,5(12): 822–834. doi: 10.1016/j.trecan.2019.10.007
    [3]
    RABOLD K, NETEA M G, ADEMA G J, et al. Cellular metabolism of tumor-associated macrophages—functional impact and consequences. FEBS Lett,2017,591(19): 3022–3041. doi: 10.1002/1873-3468.12771
    [4]
    DENARDO D G, RUFFELL B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol,2019,19(6): 369–382. doi: 10.1038/s41577-019-0127-6
    [5]
    SHANG S, JI X, ZHANG L, et al. Macrophage ABHD5 suppresses NFkappaB-dependent matrix metalloproteinase expression and cancer metastasis. Cancer Res,2019,79(21): 5513–5526.
    [6]
    MIAO H, OU J, PENG Y, et al. Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM. Nat Commun, 2016, 7: 11716[2020-11-03]. https://www.nature.com/articles/ncomms11716. doi: 10.1038/ncomms11716.
    [7]
    XIANG W, SHI R, KANG X, et al. Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nat Commun,2018,9(1): 2574–2586. doi: 10.1038/s41467-018-04999-8
    [8]
    OU J, MIAO H, MA Y, et al. Loss of ABHD5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition. Cell Rep,2014,9(5): 1798–1811. doi: 10.1016/j.celrep.2014.11.016
    [9]
    SU P, WANG Q, BI E, et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res,2020,80(7): 1438–1450. doi: 10.1158/0008-5472.CAN-19-2994
    [10]
    VATS D, MUKUNDAN L, ODEGAARD J I, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab,2006,4(1): 13–24. doi: 10.1016/j.cmet.2006.05.011
    [11]
    MARÉCHAL L, LAVIOLETTE M, RODRIGUE-WAY A, et al. The CD36-PPARγ pathway in metabolic disorders. Int J Mol Sci,2018,19(5): 1529–1544. doi: 10.3390/ijms19051529
    [12]
    WU L, ZHANG X, ZHENG L, et al. RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis. Cancer Immunol Res,2020,8(5): 710–721. doi: 10.1158/2326-6066.CIR-19-0261
    [13]
    DENG X, ZHANG P, LIANG T, et al. Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARgamma and NF-kappaB pathways. Int J Mol Med,2015,36(2): 449–454. doi: 10.3892/ijmm.2015.2230
    [14]
    ZHANG Q, WANG H, MAO C, et al. Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration. Mol Immunol, 2018, 94: 27-35[2020-11-03]. https://pubmed.ncbi.nlm.nih.gov/29248877/. doi: 10.1016/j.molimm.2017.12.011.
    [15]
    ZELENAY S, VAN DER VEEN A G, BÖTTCHER J P, et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell,2015,162(6): 1257–1270. doi: 10.1016/j.cell.2015.08.015
    [16]
    CEN B, LANG J D, DU Y, et al. Prostaglandin E2 induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression. Gastroenterology, 2020, 158(4): 971-984.e10[2020-11-03]. https://pubmed.ncbi.nlm.nih.gov/31734182/. doi: 10.1053/j.gastro.2019.11.013.
    [17]
    WANG D, DUBOIS R N. Role of prostanoids in gastrointestinal cancer. J Clin Invest,2018,128(7): 2732–2742. doi: 10.1172/JCI97953
    [18]
    FENG M, JIANG W, KIM B Y S, et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nature Reviews Cancer,2019,19(10): 568–586. doi: 10.1038/s41568-019-0183-z
    [19]
    PRIMA V, KALIBEROVA L N, KALIBEROV S, et al. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc Natl Acad Sci U S A,2017,114(5): 1117–1122. doi: 10.1073/pnas.1612920114
    [20]
    BIANCHINI F, MASSI D, MARCONI C, et al. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. Prostaglandins Other Lipid Mediat,2007,83(4): 320–328. doi: 10.1016/j.prostaglandins.2007.03.003
    [21]
    RINGLEB J, STRACK E, ANGIONI C, et al. Apoptotic cancer cells suppress 5-lipoxygenase in tumor-associated macrophages. J Immunol,2018,200(2): 857–868. doi: 10.4049/jimmunol.1700609
    [22]
    DAURKIN I, ERUSLANOV E, STOFFS T, et al. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res,2011,71(20): 6400–6409. doi: 10.1158/0008-5472.CAN-11-1261
    [23]
    MCKILLOP I H, GIRARDI C A, THOMPSON K J. Role of fatty acid binding proteins (FABPs) in cancer development and progression. Cell Signal, 2019, 62: 109336[2020-11-03]. https://pubmed.ncbi.nlm.nih.gov/31170472/. doi: 10.1016/j.cellsig.2019.06.001.
    [24]
    ELSHERBINY M E, EMARA M, GODBOUT R. Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma. Prog Lipid Res,2013,52(4): 562–570. doi: 10.1016/j.plipres.2013.08.004
    [25]
    ZHANG Y, SUN Y, RAO E, et al. Fatty acid-binding protein E-FABP restricts tumor growth by promoting IFN-β responses in tumor-associated macrophages. Cancer Res,2014,74(11): 2986–2998. doi: 10.1158/0008-5472.CAN-13-2689
    [26]
    RAO E, SINGH P, ZHAI X, et al. Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein. Oncotarget,2015,6(10): 7815–7827. doi: 10.18632/oncotarget.3485
    [27]
    HAO J, YAN F, ZHANG Y, et al. Expression of adipocyte/macrophage fatty acid-binding protein in tumor-associated macrophages promotes breast cancer progression. Cancer Res,2018,78(9): 2343–2355. doi: 10.1158/0008-5472.CAN-17-2465
    [28]
    VAN DER VORST E P C, THEODOROU K, WU Y, et al. High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kappaB/STAT1-IRF1 signaling. Cell Metab,2017,25(1): 197–207. doi: 10.1016/j.cmet.2016.10.013
    [29]
    GOOSSENS P, RODRIGUEZ-VITA J, ETZERODT A, et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab, 2019, 29(6): 1376−1389.e4[2020-11-03]. https://pubmed.ncbi.nlm.nih.gov/30930171/. doi: 10.1016/j.cmet.2019.02.016.
    [30]
    WANG N, LAN D, CHEN W, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A,2004,101(26): 9774–9779. doi: 10.1073/pnas.0403506101
    [31]
    SAG D, CEKIC C, WU R, et al. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat Commun, 2015, 6: 6354[2020-11-03]. https://www.nature.com/articles/ncomms7354. doi: 10.1038/ncomms7354.
    [32]
    SHI S Z, LEE E J, LIN Y J, et al. Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer. Am J Cancer Res,2019,9(10): 2194–2208.
    [33]
    PARK S J, LEE K P, KANG S, et al. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4. Cell Signal,2014,26(10): 2249–2258. doi: 10.1016/j.cellsig.2014.07.009
    [34]
    MACIEL E, NEVES B M, MARTINS J, et al. Oxidized phosphatidylserine mitigates LPS-triggered macrophage inflammatory status through modulation of JNK and NF-kB signaling cascades. Cell Signal, 2019, 61: 30-38.
    [35]
    REINARTZ S, LIEBER S, PESEK J, et al. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment. Mol Oncol,2019,13(2): 185–201. doi: 10.1002/1878-0261.12396
    [36]
    BIAN D, SU S, MAHANIVONG C, et al. Lysophosphatidic acid stimulates ovarian cancer cell migration via a Ras-MEK kinase 1 pathway. Cancer Res,2004,64(12): 4209–4217. doi: 10.1158/0008-5472.CAN-04-0060
    [37]
    HOUBEN A J, MOOLENAAR W H. Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev,2011,30(3/4): 557–565. doi: 10.1007/s10555-011-9319-7
    [38]
    ZHANG D, SHI R, XIANG W, et al. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages. Signal Transduct Target Ther,2020,5(1): 24–36. doi: 10.1038/s41392-020-0117-y
    [39]
    RABOLD K, ASCHENBRENNER A, THIELE C, et al. Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics. J Immunother Cancer, 2020, 8(2): e000638[2020-11-03]. https://pubmed.ncbi.nlm.nih.gov/32943450/. doi: 10.1136/jitc-2020-000638.
    [40]
    EMANUELE S, D'ANNEO A, CALVARUSO G, et al. The double-edged sword profile of redox signaling: oxidative events as molecular switches in the balance between cell physiology and cancer. Chem Res Toxicol,2018,31(4): 201–210. doi: 10.1021/acs.chemrestox.7b00311
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Article views (1649) PDF downloads(130) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return